Search
for
Sort by
Research 421–450 of 994
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Male hormonal contraception: looking back and moving forward
- The Pathogenesis of Alopecia Areata in Rodent Models
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change
- Deciphering principles of morphogenesis from temporal and spatial patterns on the integument
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Polycystic Ovarian Syndrome in Adolescents
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Congenital adrenal hyperplasia
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- Isoallopregnanolone reduces tic‐like behaviours in the D1 CT ‐7 mouse model of Tourette syndrome
- A bibliometric study of scientific literature in Scopus on botanicals for treatment of androgenetic alopecia
- Distribution of 1,25-dihydroxyvitamin D3[22-oxa] in vivo receptor binding in adult and developing skin
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- Morpho‐regulation in diverse chicken feather formation: Integrating branching modules and sex hormone‐dependent morpho‐regulatory modules
- A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Acromegaloidism with normal growth hormone secretion associated with X-Tetrasomy
- Hirsutism and virilization